Shal has voluntarily divested himself entirely of all personal investments in the pharmaceutical and medical device industries that could be perceived as a conflict of interest.
Shal brings a unique perspective at a time when the College is ramping up to meet the evolving needs of cardiovascular professionals domestically and around the globe.